Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rifkin

Showing results (81-90 of 191) with videos related to

Pageof 20
Sort By:
Psychosomatics|May 26, 1999
Religious and other predictors of psychosocial adjustment in cancer patientsA Rifkin, S Doddi, B Karagji, et al.
Nature Genetics|January 28, 2003
Evolution of gene expression in the Drosophila melanogaster subgroupScott A Rifkin, Junhyong Kim, Kevin P White
Trends in Genetics : TIG|July 4, 2008
Revealing the architecture of gene regulation: the promise of eQTL studiesYoav Gilad, Scott A Rifkin, Jonathan K Pritchard
Psychopharmacology Bulletin|January 1, 1990
Dose and blood levels of haloperidol in treatment of maniaA Rifkin, B Karajgi, S Doddi, et al.
Psychopharmacology Bulletin|January 1, 1981
Evaluation of a training program in using the research diagnostic criteria [proceedings]A Rifkin, G Reardon, S Siris, et al.
Psychopharmacology Bulletin|July 1, 1977
Is prophylactic procyclidine necessary?A Rifkin, F Quitkin, J Kane, et al.
Trends in Pharmacological Sciences|February 12, 2017
G Protein-Gated Potassium Channels: A Link to Drug AddictionRobert A Rifkin, Stephen J Moss, Paul A Slesinger
Psychopharmacologia|October 31, 1975
A study of abrupt lithium withdrawalA Rifkin, F Quitkin, A Howard, et al.
Psychopharmacology Bulletin|April 1, 1977
Fluphenazine decanoate, oral fluphenazine, and placebo in the treatment of remitted schizophrenics. II. Rating scale data [proceedings]A Rifkin, F Quitkin, J Kane, et al.
Archives of General Psychiatry|March 1, 1986
Facial discrimination and emotional recognition in schizophrenia and affective disordersT E Feinberg, A Rifkin, C Schaffer, et al.
Pageof 20

Showing results (81-90 of 191) with videos related to

Sort By:
Pageof 20
Psychosomatics|May 26, 1999
Religious and other predictors of psychosocial adjustment in cancer patientsA Rifkin, S Doddi, B Karagji, et al.
Nature Genetics|January 28, 2003
Evolution of gene expression in the Drosophila melanogaster subgroupScott A Rifkin, Junhyong Kim, Kevin P White
Trends in Genetics : TIG|July 4, 2008
Revealing the architecture of gene regulation: the promise of eQTL studiesYoav Gilad, Scott A Rifkin, Jonathan K Pritchard
Psychopharmacology Bulletin|January 1, 1990
Dose and blood levels of haloperidol in treatment of maniaA Rifkin, B Karajgi, S Doddi, et al.
Psychopharmacology Bulletin|January 1, 1981
Evaluation of a training program in using the research diagnostic criteria [proceedings]A Rifkin, G Reardon, S Siris, et al.
Psychopharmacology Bulletin|July 1, 1977
Is prophylactic procyclidine necessary?A Rifkin, F Quitkin, J Kane, et al.
Trends in Pharmacological Sciences|February 12, 2017
G Protein-Gated Potassium Channels: A Link to Drug AddictionRobert A Rifkin, Stephen J Moss, Paul A Slesinger
Psychopharmacologia|October 31, 1975
A study of abrupt lithium withdrawalA Rifkin, F Quitkin, A Howard, et al.
Psychopharmacology Bulletin|April 1, 1977
Fluphenazine decanoate, oral fluphenazine, and placebo in the treatment of remitted schizophrenics. II. Rating scale data [proceedings]A Rifkin, F Quitkin, J Kane, et al.
Archives of General Psychiatry|March 1, 1986
Facial discrimination and emotional recognition in schizophrenia and affective disordersT E Feinberg, A Rifkin, C Schaffer, et al.
Pageof 20